The role of neuromodulation in heart failure with preserved ejection fraction
Algheffari J, Salameh AR, Adil L, Hameed A, Araz K
Current Problems in Cardiology · 2025
Key finding
Neuromodulation therapies show potential in improving symptoms and QoL for HFpEF patients.
- Condition
- Kidney Disease
- Stimulation
- iVNS
- Evidence tier
- Narrative / Scoping Review
- Participants
- —
Cite this study
Algheffari, J., Salameh, A. R., Adil, L., Hameed, A., & Araz, K. (2025). The role of neuromodulation in heart failure with preserved ejection fraction. Current Problems in Cardiology, 50(12), 103189. https://doi.org/10.1016/j.cpcardiol.2025.103189
Related studies in Kidney Disease
Transcutaneous auricular vagus nerve stimulation improves cognitive decline by alleviating intradialytic cerebral hypoxia in hemodialysis patients: A fNIRS pilot study
Wang et al. · Heliyon · 2024 · Controlled Clinical Trial
Neuroimmune Control of Inflammation in Acute Kidney Injury and Multiorgan Dysfunction
Goggins et al. · Journal of the American Society of Nephrology : JASN · 2025 · Narrative / Scoping Review
Vagal modulation of hypertension
Petkovich et al. · Current hypertension reports · 2015 · Narrative / Scoping Review
Summary by Vagus Research. Always consult the primary source for the authoritative record.